168 related articles for article (PubMed ID: 8443399)
1. Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.
Ewers SB; Attewell R; Baldetorp B; Borg A; Fernö M; Långström E; Killander D
Breast Cancer Res Treat; 1992; 24(2):115-26. PubMed ID: 8443399
[TBL] [Abstract][Full Text] [Related]
2. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer.
Balslev I; Christensen IJ; Rasmussen BB; Larsen JK; Lykkesfeldt AE; Thorpe SM; Rose C; Briand P; Mouridsen HT
Int J Cancer; 1994 Jan; 56(1):16-25. PubMed ID: 8262673
[TBL] [Abstract][Full Text] [Related]
4. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
Pinto AE; André S; Pereira T; Silva G; Soares J
Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
[TBL] [Abstract][Full Text] [Related]
5. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.
Yokoe T; Izuo M; Ishida T; Iino Y; Kawai T
Jpn J Surg; 1990 Sep; 20(5):491-7. PubMed ID: 2243441
[TBL] [Abstract][Full Text] [Related]
7. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
8. Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.
Ewers SB; Attewell R; Baldetorp B; Borg A; Långström E; Killander D
Breast Cancer Res Treat; 1992 Jan; 20(2):93-108. PubMed ID: 1554892
[TBL] [Abstract][Full Text] [Related]
9. C-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER+) breast cancer patients with poor prognosis.
Pinto AE; André S; Pereira T; Nóbrega S; Soares J
Ann Oncol; 2001 Apr; 12(4):525-33. PubMed ID: 11398888
[TBL] [Abstract][Full Text] [Related]
10. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
Prasad AR; Divine G; Zarbo RJ
Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
[TBL] [Abstract][Full Text] [Related]
12. Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.
Lipponen P; Eskelinen M; Papinaho S; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
Anticancer Res; 1992; 12(3):677-82. PubMed ID: 1622125
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
14. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
16. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
[TBL] [Abstract][Full Text] [Related]
17. Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients.
Stål O; Carstensen J; Hatschek T; Nordenskjöld B
Br J Cancer; 1992 Oct; 66(4):706-11. PubMed ID: 1419611
[TBL] [Abstract][Full Text] [Related]
18. Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group.
Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
Int J Cancer; 1992 Apr; 51(1):28-33. PubMed ID: 1563841
[TBL] [Abstract][Full Text] [Related]
19. Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer.
Railo M; Lundin J; Haglund C; von Smitten K; von Boguslawsky K; Nordling S
Acta Oncol; 1997; 36(4):369-74. PubMed ID: 9247096
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]